Literature DB >> 20526697

Diffuse cerebral intravascular coagulation and cerebral infarction in pneumococcal meningitis.

Mervyn D I Vergouwen1, Ewout S Schut, Dirk Troost, Diederik van de Beek.   

Abstract

BACKGROUND: There is a widely held belief that cerebral infarction after bacterial meningitis is always caused by vasculitis; however, evidence is weak. We hypothesized that diffuse cerebral intravascular coagulation is an additional explanation of cerebral infarction in patients with pneumococcal meningitis.
METHODS: Sixteen brains of adults who died from pneumococcal meningitis were investigated. Clinical data were collected, and brain sections were scored for signs of inflammation and activation of coagulation. Patients with and without cerebral infarction on autopsy were compared.
RESULTS: In total, 38% of patients had focal neurological deficits. Patients died at a median of 7 days (range, 0-32 days) after admission. On autopsy, the nine patients (56%) with cerebral infarctions more often had arterial thrombosis (p = 0.04) than patients without infarction. Patients with infarction tended to have more inflammatory infiltrations of brain parenchyma, microvascular proliferation, small vessel vasculitis/endarteritis obliterans, blood clotting/vessel clogging, and venous thrombosis. None of the patients had large vessel vasculitis. Five patients had cerebral infarctions without vasculitis or endarteritis obliterans. Although four patients with cerebral infarctions had small vessel vasculitis or endarteritis obliterans, areas of infarction could not be localized to the blood flow distribution of these vessels. Blood clotting/vessel clogging was seen in all four patients with vasculitis or endarteritis obliterans, but this was also observed in 10 patients without vasculitis or endarteritis obliterans. None of the patients developed disseminated intravascular coagulation.
CONCLUSIONS: Our results suggest that diffuse cerebral intravascular coagulation is an additional explanation of cerebral infarction complicating pneumococcal meningitis.

Entities:  

Mesh:

Year:  2010        PMID: 20526697     DOI: 10.1007/s12028-010-9387-5

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  23 in total

Review 1.  Bidirectional relation between inflammation and coagulation.

Authors:  Marcel Levi; Tom van der Poll; Harry R Büller
Journal:  Circulation       Date:  2004-06-08       Impact factor: 29.690

2.  Procoagulant and fibrinolytic activity in cerebrospinal fluid from adults with bacterial meningitis.

Authors:  Martijn Weisfelt; Rogier M Determann; Jan de Gans; Arie van der Ende; Marcel Levi; Diederik van de Beek; Marcus J Schultz
Journal:  J Infect       Date:  2007-01-04       Impact factor: 6.072

3.  Failure of heparin to alter the outcome of pneumococcal meningitis.

Authors:  J T MacFarlane; P G Cleland; E D Attai; B M Greenwood
Journal:  Br Med J       Date:  1977-12-10

4.  Brain infarcts in adults with bacterial meningitis.

Authors:  W Weststrate; A Hijdra; J de Gans
Journal:  Lancet       Date:  1996-02-10       Impact factor: 79.321

5.  Role of the urokinase plasminogen activator system in patients with bacterial meningitis.

Authors:  Frank Winkler; Stefan Kastenbauer; Uwe Koedel; H Walter Pfister
Journal:  Neurology       Date:  2002-11-12       Impact factor: 9.910

6.  Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series.

Authors:  Martijn Weisfelt; Diederik van de Beek; Lodewijk Spanjaard; Johannes B Reitsma; Jan de Gans
Journal:  Lancet Neurol       Date:  2006-02       Impact factor: 44.182

7.  High-dose glucocorticosteroids increase the procoagulant effects of OKT3.

Authors:  D Abramowicz; O Pradier; L De Pauw; P Kinnaert; O Mat; M Surquin; J M Doutrelepont; J L Vanherweghem; P Capel; P Vereerstraeten
Journal:  Kidney Int       Date:  1994-12       Impact factor: 10.612

Review 8.  Pneumococcal meningitis in adults: new approaches to management and prevention.

Authors:  Martijn Weisfelt; Jan de Gans; Tom van der Poll; Diederik van de Beek
Journal:  Lancet Neurol       Date:  2006-04       Impact factor: 44.182

Review 9.  Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis.

Authors:  E S Schut; M C Brouwer; J de Gans; S Florquin; D Troost; D van de Beek
Journal:  Neurology       Date:  2009-11-04       Impact factor: 9.910

10.  Endothelin inhibition improves cerebral blood flow and is neuroprotective in pneumococcal meningitis.

Authors:  L A Pfister; J H Tureen; S Shaw; S Christen; D M Ferriero; M G Täuber; S L Leib
Journal:  Ann Neurol       Date:  2000-03       Impact factor: 10.422

View more
  25 in total

1.  Understanding coma in bacterial meningitis.

Authors:  R Sonneville; G Citerio; G Meyfroidt
Journal:  Intensive Care Med       Date:  2015-09-28       Impact factor: 17.440

2.  Raised intracranial pressure during CNS infection: what should we do about it?*.

Authors:  Robert C Tasker
Journal:  Crit Care Med       Date:  2014-08       Impact factor: 7.598

Review 3.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

4.  Bedside evaluation of cerebral energy metabolism in severe community-acquired bacterial meningitis.

Authors:  Frantz R Poulsen; Mette Schulz; Anne Jacobsen; Åse B Andersen; Lykke Larsen; Wilhelm Schalén; Troels H Nielsen; Carl-Henrik Nordström
Journal:  Neurocrit Care       Date:  2015-04       Impact factor: 3.210

Review 5.  Arterial ischemic stroke in children: risk factors and etiologies.

Authors:  Adam L Numis; Christine K Fox
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

6.  Elevated soluble urokinase receptor values in CSF, age and bacterial meningitis infection are independent and additive risk factors of fatal outcome.

Authors:  G Tzanakaki; M Paparoupa; M Kyprianou; A Barbouni; J Eugen-Olsen; J Kourea-Kremastinou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-05       Impact factor: 3.267

7.  Delayed cerebral thrombosis in bacterial meningitis: a prospective cohort study.

Authors:  Marjolein J Lucas; Matthijs C Brouwer; Diederik van de Beek
Journal:  Intensive Care Med       Date:  2012-12-18       Impact factor: 17.440

8.  Pneumococcal meningitis, cerebral venous thrombosis, and cervical arterial dissection: a run of bad luck?

Authors:  Mauricio Isaac Panicio; Renato Demarchi Foresto; Lucas Mateus; Paulo Helio Monzillo; Monique Bueno Alves; Gisele Sampaio Silva
Journal:  Neurohospitalist       Date:  2013-01

9.  Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis.

Authors:  Bianca Woehrl; Matthijs C Brouwer; Carmen Murr; Sebastiaan G B Heckenberg; Frank Baas; Hans W Pfister; Aeilko H Zwinderman; B Paul Morgan; Scott R Barnum; Arie van der Ende; Uwe Koedel; Diederik van de Beek
Journal:  J Clin Invest       Date:  2011-09-19       Impact factor: 14.808

10.  Intracerebral hemorrhages in adults with community associated bacterial meningitis in adults: should we reconsider anticoagulant therapy?

Authors:  Barry B Mook-Kanamori; Daan Fritz; Matthijs C Brouwer; Arie van der Ende; Diederik van de Beek
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.